Our Products

See our range of cfDNA products below.

Pre-Analytical

Ensuring successful cfDNA analysis is our focus

Every sample is precious and to get the most out of your sample when evaluating cfDNA it is really critical to have processed your samples correctly from blood collection through to extracted cfDNA. Learn more about our Cell3 Preserver blood tube and Cell3 Xtract kit below.

Prenatal Healthcare

Non-invasive prenatal testing requires sensitive, reproducible and easy to use products.

Nonacus continues to develop innovative products to meet these exacting standards including tests for fetal rhesus-D genotyping, fetal fraction quantitation and single gene disorder testing.

Oncology

Efficient workflow enables confident calling of all ctDNA mutations

Nonacus are working with some of the brightest scientists and clinicians by providing a validated complete workflow for liquid biopsy analysis. With the ultimate goal of enabling better cancer care through earlier diagnosis, treatment stratification and monitoring.

Who we are

Designed by scientists, for Scientists

We are formed of a committed group of biotechnology professionals with a combined 35 years experience in genomic healthcare. We understand the pressure on laboratories to deliver progress and our products are designed to get you there. Between us, we’ve got global experience of genomic healthcare from the NHS in the UK through to an international genome project.

Designed by scientists
True Innovation

What we stand for

True Innovation That Benefits Patients

We translate research into routine diagnostic tools that directly benefit patients and scientists. Our non-invasive cell free DNA solutions improve diagnostic accuracy as well as the patient’s experience. Our research & development team are constantly developing, validating and testing new cfDNA products.

Built For Labs That Do

Universities

We supply Universities with our cfDNA products to help them improve their understanding and research in non-invasive healthcare.

Hospitals

Leading hospitals have adopted our products to help improve patient care through the innovative use of cfDNA technology allowing for non-invasive diagnostics.

Research Facilities

We partner with many leading laboratories to constantly innovate and push our products further.

Research Facilities

Read Our Latest Insights

27–30 May 2017 – Nonacus ESHG 2017 Abstract Accepted

March 26, 2017

Dr Michael Parks, previous recipient of the ESHG young investigator award, will be presenting a poster on our innovative Plasma Cell3TMDirect qPCR technology at the ESHG 2017 conference in Copenhagen:‘A direct from plasma approach to non-invasive prenatal fetal sex determination and RhesusD genotyping by quantitative PCR’(Control No. 2017-A-719-ESHG).

Read More

6-7th April – cfDNA 2017 Copenhagen

March 1, 2017

Nonacus is attending and sponsoring the 3rd International Meeting on Cell Free DNA conference in Copenhagen. Come and visit the team at booth H. Dr Michael Parks will be presenting our technology at the conference : A direct from plasma approach for non-invasive fetal RhesusD genotyping April 06, 2017, 16:10-16:45.

Read More

1st July 2016 – Nonacus Open R&D Laboratory at the BioHub Birmingham

July 1, 2016

We are pleased to announce that we have moved into our new business premises and laboratory at the Birmingham BioHub. The facility offers purpose built state of the art laboratory and office space. The team are looking forward to getting to work and making the most of the new facilities.

Read More

Are you ready to innovate your cfDNA capability?

Contact us for a quote.